Typhim Vi Injection, Solution
NDC Package 49281-790-20
Package Information
Typhim Vi (salmonella typhi ty2 vi polysaccharide antigen) injection is typhim Vi vaccine is indicated for active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older. This formulation utilizes a injection, solution delivery system. Marketed by Sanofi Vaccines Us Inc., this product is identified by NDC 49281-790 and is authorized under FDA application BLA103936.
Identification & Billing
- RxCUI: 1486496 - Typhim Vi 0.5 ML Prefilled Syringe
- RxCUI: 1486496 - 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI]
- RxCUI: 1486496 - 0.5 ML Typhim VI 0.05 MG/ML Prefilled Syringe
- RxCUI: 1486496 - Typhim VI 25 MCG per 0.5 ML Prefilled Syringe
- RxCUI: 807222 - typhoid Vi polysaccharide vaccine (generic for Typhim Vi) Injectable Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49281 - Sanofi Vaccines Us Inc.
- 49281-790 - Typhim Vi
- 49281-790-20 - 1 VIAL, MULTI-DOSE in 1 PACKAGE / 10 mL in 1 VIAL, MULTI-DOSE (49281-790-38)
- 49281-790 - Typhim Vi
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (49281-790). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49281-790-20 identifies a specific commercial package of 1 vial, multi-dose in 1 package / 10 ml in 1 vial, multi-dose (49281-790-38) of Typhim Vi, a vaccine label labeled by Sanofi Vaccines Us Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 10 billable units per package. This injection, solution is formulated for intramuscular use and contains salmonella typhi ty2 vi polysaccharide antigen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sanofi Vaccines Us Inc. on November 28, 1994. The current certification is valid through December 31, 2027.
How is this Sanofi Vaccines Us Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49281079020. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.